We need your support to keep TheyWorkForYou running and make sure people across the UK can continue to hold their elected representatives to account.

Donate to our crowdfunder

Armed Forces: Malaria

House of Lords written question – answered on 7th November 2014.

Alert me about debates like this

Photo of Baroness Corston Baroness Corston Chair, EU Sub Committee E - Justice, Institutions and Consumer Protection

To ask Her Majesty’s Government what factors are taken into account when administering larium as a malaria prophylactic to British troops and reservists serving overseas.

Photo of Lord Astor of Hever Lord Astor of Hever The Parliamentary Under-Secretary of State for Defence

Mefloquine (commercially known as Lariam) is one of a number of effective methods of malaria chemoprophylaxis used by the military in many parts of the world where Service personnel deploy. The exact choice of drug depends on a number of factors, including the region the individual is deploying to, the health of the individual and any history of side effects. Mefloquine and other antimalarial drugs used by the military are licensed in the UK by the Medicines and Healthcare Products Regulatory Agency, based on the expert guidance of the Advisory Committee for Malaria Prevention of Public Health England. The Ministry of Defence reviews its policy on the use of antimalarial drugs in line with advice from the Advisory Committee.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.